Literature DB >> 19247666

Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Honsoul Kim1, Mi-Suk Park, Jin Young Choi, Young Nyun Park, Myeong-Jin Kim, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han, EunJu Kim, Ki Whang Kim.   

Abstract

Microvessel invasion is a major prognostic factor in hepatocellular carcinoma (HCC) that influences the suitability of surgery, but rarely can be evaluated preoperatively. This study was performed to identify preoperative MRI findings that reflect histopathological microvessel invasion in hepatocellular carcinoma. Gadobenate dimeglumine-enhanced four-arterial phase dynamic study and hepatobiliary phase images of preoperative MRI of 70 HCC lesions were retrospectively reviewed. Tumor size (cm), peritumoral enhancement, tumor margins, and radiological capsule were analyzed as radiological parameters reflecting microvessel invasion and were compared with histopathological references. The chi-square test and the independent t-test were used for univariate analysis, and a logistic regression analysis was performed for multivariate analysis. In univariate analysis, tumor size (p = 0.030), peritumoral enhancement (p < 0.001), and tumor margins (p = 0.007) were associated with microvessel tumor invasion. However, in multivariate analysis irregular circumferential peritumoral enhancement only showed statistical significance (odds ratio 13.0), suggesting a high probability of microvessel invasion of HCC. Irregular circumferential peritumoral enhancement on contrast-enhanced multi-arterial phase dynamic MRI could be a preoperative surrogate marker for microvessel tumor invasion.

Entities:  

Mesh:

Year:  2009        PMID: 19247666     DOI: 10.1007/s00330-009-1331-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

Review 1.  Staging and current treatment of hepatocellular carcinoma.

Authors:  Hollins P Clark; W Forrest Carson; Peter V Kavanagh; Coty P H Ho; Perry Shen; Ronald J Zagoria
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

2.  Liver transplantation for hepatocellular carcinoma.

Authors:  A W Hemming; M S Cattral; A I Reed; W J Van Der Werf; P D Greig; R J Howard
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

3.  Time-resolved, high-resolution contrast-enhanced MR angiography of dialysis shunts using the CENTRA keyhole technique with parallel imaging.

Authors:  Katja A Mende; Johannes M Froehlich; Constantin von Weymarn; Romhild Hoogeveen; Thomas Kistler; Christoph L Zollikofer; Klaus U Wentz
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

4.  Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for 3D contrast-enhanced abdominal imaging.

Authors:  Gabriele M Beck; Jan De Becker; Alun C Jones; Marcus von Falkenhausen; Winfried A Willinek; Jürgen Gieseke
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

5.  Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique.

Authors:  Hye-Suk Hong; Hua Sun Kim; Myeong-Jin Kim; Jan De Becker; Donald G Mitchell; Masayuki Kanematsu
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

6.  Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Yoshiki Asayama; Hiroyuki Irie; Tsuyoshi Tajima; Masakazu Hirakawa; Kousei Ishigami; Tomohiro Nakayama; Daisuke Kakihara; Yunosuke Nishihara; Akinobu Taketomi; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

7.  Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.

Authors:  Young Kon Kim; Jeong Min Lee; Chong Soo Kim
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

8.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

9.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

Review 10.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

View more
  47 in total

1.  Microvascular invasion in hepatocellular carcinoma.

Authors:  Emre Ünal; İlkay Sedakat İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies.

Authors:  Alfonso Reginelli; Angelo Vanzulli; Cristiano Sgrazzutti; Luca Caschera; Nicola Serra; Antonio Raucci; Fabrizio Urraro; Salvatore Cappabianca
Journal:  Med Oncol       Date:  2017-04-12       Impact factor: 3.064

Review 3.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

4.  Pre-operative Microvascular Invasion Prediction Using Multi-parametric Liver MRI Radiomics.

Authors:  Giacomo Nebbia; Qian Zhang; Dooman Arefan; Xinxiang Zhao; Shandong Wu
Journal:  J Digit Imaging       Date:  2020-12       Impact factor: 4.056

5.  Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging.

Authors:  C-T Chou; R-C Chen; C-W Lee; C-J Ko; H-K Wu; Y-L Chen
Journal:  Br J Radiol       Date:  2011-08-09       Impact factor: 3.039

6.  Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.

Authors:  Shengtao Lin; Feng Ye; Weiqi Rong; Ying Song; Fan Wu; Yunhe Liu; Yiling Zheng; Tana Siqin; Kai Zhang; Liming Wang; Jianxiong Wu
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

7.  Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim; Jisun Lee; Kyoung Doo Song; Min Woo Lee; Young-Sun Kim; Hyo Keun Lim; Kyung Mi Jang; Seong Hyun Kim; Geum-Youn Gwak; Sin-Ho Jung
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

8.  Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.

Authors:  Sunyoung Lee; Kyoung Won Kim; Woo Kyoung Jeong; Myeong-Jin Kim; Gi Hong Choi; Jin Sub Choi; Gi-Won Song; Sung-Gyu Lee
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

9.  CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma.

Authors:  Yueming Li; Xuru Xu; Shuping Weng; Chuan Yan; Jianwei Chen; Rongping Ye
Journal:  J Digit Imaging       Date:  2020-09-23       Impact factor: 4.056

10.  Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.

Authors:  Matteo Renzulli; Federica Buonfiglioli; Fabio Conti; Stefano Brocchi; Ilaria Serio; Francesco Giuseppe Foschi; Paolo Caraceni; Giuseppe Mazzella; Gabriella Verucchi; Rita Golfieri; Pietro Andreone; Stefano Brillanti
Journal:  Eur Radiol       Date:  2017-09-11       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.